US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug
CNN
1 min read
21

US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug

June 30, 2021
0

www.cnn.com Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.… Read More

Continue Reading